-
1
المؤلفون: Xin Wei Wang, Ole Larsen, Julia S. Johansen, Colm J O'Rourke, Dan Høgdall, Jesper B. Andersen, Morten Mau-Sørensen, Mogens Karsboel Boisen, Astrid Z. Johansen, Dorte Linnemann, Hien Dang, Douglas V. N. P. Oliveira, Valentina M. Factor, Lars Henrik Jensen, Christian Dehlendorff, Mie Grunnet
المصدر: Høgdall, D, O'Rourke, C J, Dehlendorff, C, Larsen, O F, Jensen, L H, Johansen, A Z, Dang, H, Factor, V M, Grunnet, M, Mau-Sørensen, M, Oliveira, D V N P, Linnemann, D, Boisen, M K, Wang, X W, Johansen, J S & Andersen, J B 2020, ' Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers ', Clinical Cancer Research, vol. 26, no. 21, pp. 5655-5667 . https://doi.org/10.1158/1078-0432.CCR-19-2700Test
Clin Cancer Resمصطلحات موضوعية: Adult, Male, musculoskeletal diseases, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Locally advanced, Inflammation, Deoxycytidine, Article, Disease-Free Survival, Mice, 03 medical and health sciences, 0302 clinical medicine, In vivo, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Animals, Humans, Antigens, Tumor-Associated, Carbohydrate, Prognostic biomarker, Chitinase-3-Like Protein 1, Aged, Cell Proliferation, Aged, 80 and over, Interleukin-6, Proportional hazards model, business.industry, Palliative Care, Middle Aged, Prognosis, Receptors, Interleukin-6, Gemcitabine, Progression-Free Survival, Clinical trial, Biliary Tract Neoplasms, 030104 developmental biology, Biliary tract, 030220 oncology & carcinogenesis, Female, medicine.symptom, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db1883a3389ee7e27bcc0a6669a1e847Test
https://doi.org/10.1158/1078-0432.ccr-19-2700Test -
2
المؤلفون: Ben Markman, Jonathan Cebon, Damien Kee, Michael Michael, Oliver Klein, Clare L. Scott, Craig Underhill, Adnan Nagrial, Louise Jackett, Jodie Palmer, Jane Yeojeong So, Matteo S. Carlino, Caroline Lum, Andreas Behren
المصدر: Clinical Cancer Research. 26:4454-4459
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Programmed Cell Death 1 Receptor, Ipilimumab, Neuroendocrine tumors, Gastroenterology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Pancreatic cancer, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, CTLA-4 Antigen, Prospective Studies, 030212 general & internal medicine, Response Evaluation Criteria in Solid Tumors, Aged, Neoplasm Staging, Aged, 80 and over, Everolimus, business.industry, Middle Aged, medicine.disease, Progression-Free Survival, Clinical trial, Neuroendocrine Tumors, Nivolumab, Clinical research, Oncology, 030220 oncology & carcinogenesis, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bfb0576b28617790aa7e0eb446129d7Test
https://doi.org/10.1158/1078-0432.ccr-20-0621Test -
3
المؤلفون: Alessia Covre, Giovanni Amato, Michele Maio, Francesca Finotello, James N. Lowder, Amelie Nemc, Santa Monterisi, Zlatko Trajanoski, Florent Petitprez, Anna Maria Di Giacomo, Sandra Coral, Andrea Lazzeri, Laetitia Lacroix, Ornella Cutaia, Riccardo Danielli, Luca Sigalotti, Wolf H. Fridman, Monica Valente, Carolina Fazio, Mohammad Azab, Andrea Anichini, Diana Giannarelli, Christoph Bock, Dietmar Rieder, Clelia Miracco, Catherine Sautès-Fridman, Aram Oganesian
المصدر: Clinical Cancer Research
مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Programmed Cell Death 1 Receptor, Ipilimumab, CD8-Positive T-Lymphocytes, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Metastasis, Adverse effect, Survival rate, Melanoma, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Cancer, DNA Methylation, Middle Aged, medicine.disease, 3. Good health, Clinical trial, Gene Expression Regulation, Neoplastic, Survival Rate, 030104 developmental biology, Treatment Outcome, Oncology, Tolerability, 030220 oncology & carcinogenesis, Azacitidine, Female, Patient Safety, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf6bf5326d9ecad92fa6c06a0e46a84eTest
-
4
المؤلفون: Véronique Diéras, Marian Degardin, Valérie Laurence, Marie-Edith Bonneterre, Jacques Bonneterre, Pierre Fumoleau, Jean-Yves Pierga, Sandrine Marreaud, Denis Lacombe
المصدر: Clinical Cancer Research. 11:6256-6260
مصطلحات موضوعية: Adult, Male, Cancer Research, Maximum Tolerated Dose, Docetaxel, Pharmacology, urologic and male genital diseases, Drug Administration Schedule, Pharmacokinetics, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, ATP Binding Cassette Transporter, Subfamily B, Member 1, Prospective Studies, neoplasms, Stomatitis, Aged, Dose-Response Relationship, Drug, business.industry, Middle Aged, medicine.disease, Clinical trial, Dose–response relationship, Treatment Outcome, Oncology, Tolerability, Area Under Curve, Toxicity, Quinolines, Female, Taxoids, business, therapeutics, Febrile neutropenia, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c6e19b2e9f422f23dcefae0de3532aTest
https://doi.org/10.1158/1078-0432.ccr-04-2316Test